Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved publishing date : 2022 - 05 - 03 save search
Jaguar Health Completes Final Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea (EID) in Dogs
Published: 2022-05-03 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | $0.1659 -6.32% 14M
|
Health Technology
|
| O: 2.18%
H: 2.17%
C: -0.41%
drug diarrhea health approval
SeaStar Medical Granted FDA Breakthrough Device Designation for a Novel Immunomodulatory Therapy for Acute Kidney Injury Patients
Published: 2022-05-03 (Crawled : 01:00) - biospace.com/
LMAO | $12.35 3.89%
|
|
| O: 0.1%
H: 0.0%
C: 0.0%
fda designation device kidney granted therapy
Sunnyside Bancorp Announces Receipt of Regulatory Approvals
Published: 2022-05-03 (Crawled : 23:00) - prnewswire.com
SNNY 4 | $20.2
|
Finance and Insurance
|
| O: 4.28%
H: 1.15%
C: 1.15%
Shareholders approve all resolutions on the agenda of Tenaris’s Annual General Meeting
Published: 2022-05-03 (Crawled : 22:00) - globenewswire.com
TS | $37.915 1.46% 420K
|
Non-Energy Minerals
|
| O: 1.29%
H: 1.6%
C: 1.3%
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA™ TRIPLE PAK™ (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA™ DUAL PAK™ (vonoprazan, amoxicillin) for the Treatment of H. pylori Infection in Adults
Published: 2022-05-03 (Crawled : 22:00) - globenewswire.com
PHAT | $9.15 -3.48% 99K
|
Health Technology
|
| O: -3.35%
H: 0.0%
C: -3.47%
treatment fda approval infection infections
Exelixis’ Partner Ipsen Receives European Commission Approval for CABOMETYX® (cabozantinib) for Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer
Published: 2022-05-03 (Crawled : 18:00) - biospace.com/
TAK | News | $13.255 0.72% 200K
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
BMY | $48.56 0.54% 1.8M
|
Health Technology
|
| O: 0.36%
H: 0.0%
C: 0.0%
EXEL | $22.41 -0.36% 530K
|
Health Technology
|
| O: 0.09%
H: 1.54%
C: -0.44%
cabometyx approval cancer
Suneva Medical Inc. Announces Multiple Regulatory Approvals in the U.S. and Canada
Published: 2022-05-03 (Crawled : 17:00) - biospace.com/
VHAQ | $10.81 0.0% 990
|
|
| O: 0.0%
H: 0.0%
C: 0.0%
canada
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-74809 for the Treatment of Idiopathic Pulmonary Fibrosis
Published: 2022-05-03 (Crawled : 13:20) - biospace.com/
PLRX | $12.2 0.08% 60K
|
Health Technology
|
| O: 0.88%
H: 2.62%
C: -5.26%
pln-7480 treatment fda fibrosis designation therapeutics fast track designation
Allied Corp Announces Approval of Psychoactive (THC) Quota for the Production of Colombian THC Cannabis Flower
Published: 2022-05-03 (Crawled : 13:00) - globenewswire.com
ALID | $0.1616 11K
|
Manufacturing
|
| O: -0.14%
H: 6.8%
C: 5.41%
cannabis thc approval
Graphite Bio Announces U.S. FDA Fast Track Designation Granted to GPH101 for the Treatment of Sickle Cell Disease
Published: 2022-05-03 (Crawled : 12:20) - biospace.com/
GRPH 4 | $3.27 1.84% 490K
|
Professional, Scientific, and T...
|
| O: -1.97%
H: 5.28%
C: 5.03%
gph101 treatment fda designation disease granted fast track designation
Global Amniotic Membrane Markets, 2022-2027: Increasing Awareness About Amniotic Membranes (AM) Due to Gaining Approval of Many Health Commissions
Published: 2022-05-03 (Crawled : 12:00) - prnewswire.com
SYK | $327.025 -0.13% 280K
|
Health Technology
|
| O: -2.04%
H: 0.0%
C: 0.0%
health approval
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S.
Published: 2022-05-03 (Crawled : 11:00) - biospace.com/
SNOA | $0.156 -0.38% 65K
|
Health Technology
|
| O: 49.22%
H: 3.27%
C: -11.84%
nanocyn approval disinfectant group
Ipsen: European Commission Approves Cabometyx® as a Second-Line Treatment for People Living With Radioactive Iodine-Refractory Differentiated Thyroid Cancer
Published: 2022-05-03 (Crawled : 08:00) - biospace.com/
TAK | News | $13.255 0.72% 200K
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
cabometyx treatment cancer
Favorable Regulatory Approvals for Novel Poultry Feeds to Assist the Market Surpass US$ 225.2 Bn by 2032
Published: 2022-05-03 (Crawled : 01:00) - prnewswire.com
SPXC | $117.75 0.07% 35K
|
Producer Manufacturing
|
| O: 1.6%
H: 3.13%
C: 1.15%
JBT | $91.11 1.56% 59K
|
Producer Manufacturing
|
| O: 0.55%
H: 1.81%
C: 1.41%
market
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
ZCMD | $1.98 36.55% 27M
|
Commercial Services
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
AULT | $0.304 25.57% 47M
|
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.